SLGL - Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.